Total Payments
$1,333
2020 Payments
$144.33
Companies
17
Transactions
42
Medicare Patients
213
Medicare Billing
$113,030
Payment Breakdown by Category
Food & Beverage$1,304 (97.8%)
Education$28.94 (2.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,304 | 39 | 97.8% |
| Education | $28.94 | 3 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $233.44 | 9 | $0 (2019) |
| Mallinckrodt LLC | $145.79 | 2 | $0 (2018) |
| Silk Road Medical, Inc. | $144.33 | 1 | $0 (2020) |
| Relypsa, Inc. | $133.54 | 6 | $0 (2019) |
| BARD PERIPHERAL VASCULAR, INC. | $128.86 | 2 | $0 (2019) |
| Abbott Laboratories | $102.46 | 1 | $0 (2017) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $90.63 | 1 | $0 (2019) |
| Keryx Biopharmaceuticals, Inc. | $85.49 | 5 | $0 (2018) |
| Genentech USA, Inc. | $62.83 | 4 | $0 (2018) |
| Daiichi Sankyo Inc. | $35.15 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $144.33 | 1 | Silk Road Medical, Inc. ($144.33) |
| 2019 | $194.66 | 7 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($90.63) |
| 2018 | $363.17 | 16 | Otsuka America Pharmaceutical, Inc. ($198.20) |
| 2017 | $631.23 | 18 | Mallinckrodt LLC ($120.54) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/16/2020 | Silk Road Medical, Inc. | ENROUTE Transcarotid Neuroprotection System (Device), ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit | Food and Beverage | In-kind items and services | $144.33 | General |
| Category: Carotid Artery Disease | ||||||
| 07/22/2019 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Nephrology | ||||||
| 06/13/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Hyperkalemia | ||||||
| 05/18/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: NEPHROLOGY | ||||||
| 05/09/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $90.63 | General |
| 04/24/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: NEPHROLOGY | ||||||
| 04/12/2019 | BARD PERIPHERAL VASCULAR, INC. | VENOVO (Device) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: PERIPHERAL VASCULAR | ||||||
| 03/04/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Hyperkalemia | ||||||
| 10/29/2018 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: NEPHROLOGY | ||||||
| 06/25/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: NEPHROLOGY | ||||||
| 06/25/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Education | In-kind items and services | $10.16 | General |
| Category: NEPHROLOGY | ||||||
| 06/25/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Education | In-kind items and services | $8.62 | General |
| Category: NEPHROLOGY | ||||||
| 06/14/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $102.96 | General |
| Category: NEPHROLOGY | ||||||
| 06/12/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Education | In-kind items and services | $10.16 | General |
| Category: NEPHROLOGY | ||||||
| 06/11/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Hyperkalemia | ||||||
| 05/29/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: KRYSTEXXA | ||||||
| 04/27/2018 | Boston Scientific Corporation | ANGIOJET (Device) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: ANGIOPLASTY | ||||||
| 04/02/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: NEPHROLOGY | ||||||
| 03/21/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Anemia | ||||||
| 03/19/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 03/05/2018 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: BioOncology/Immunology | ||||||
| 02/07/2018 | Keryx Biopharmaceuticals, Inc. | Auryxia (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Nephrology | ||||||
| 02/05/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: KRYSTEXXA | ||||||
| 11/27/2017 | Keryx Biopharmaceuticals, Inc. | Auryxia (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 98 | 162 | $51,367 | $22,541 |
| 2022 | 2 | 32 | 109 | $66,312 | $27,098 |
| 2021 | 2 | 40 | 123 | $74,520 | $33,243 |
| 2020 | 2 | 43 | 134 | $81,216 | $30,148 |
Total Patients
213
Total Services
528
Medicare Billing
$113,030
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 11 | 32 | $17,280 | $7,679 | 44.4% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 14 | 24 | $15,552 | $6,917 | 44.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 49 | 78 | $11,622 | $5,032 | 43.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 15 | $3,195 | $1,491 | 46.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 13 | $3,718 | $1,421 | 38.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 21 | 69 | $44,712 | $18,104 | 40.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 11 | 40 | $21,600 | $8,994 | 41.6% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 23 | 75 | $48,600 | $21,387 | 44.0% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 17 | 48 | $25,920 | $11,856 | 45.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 22 | 82 | $53,136 | $19,638 | 37.0% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 21 | 52 | $28,080 | $10,510 | 37.4% |
About Dr. Samir Kumar, MD
Dr. Samir Kumar, MD is a Nephrology healthcare provider based in Lombard, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1568460145.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samir Kumar, MD has received a total of $1,333 in payments from pharmaceutical and medical device companies, with $144.33 received in 2020. These payments were reported across 42 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,304).
As a Medicare-enrolled provider, Kumar has provided services to 213 Medicare beneficiaries, totaling 528 services with total Medicare billing of $113,030. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Lombard, IL
- Active Since 07/08/2005
- Last Updated 01/25/2023
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1568460145
Products in Payments
- JYNARQUE (Drug) $161.66
- ACTHAR (Biological) $145.79
- ENROUTE Transcarotid Neuroprotection System (Device) $144.33
- Veltassa (Drug) $133.54
- BPV-Fluency (Device) $110.81
- CardioMEMS HF System (Device) $102.46
- Auryxia (Drug) $85.49
- SAMSCA (Drug) $71.78
- Rituxan (Biological) $62.83
- INJECTAFER (Drug) $35.15
- ANGIOJET (Device) $32.81
- KRYSTEXXA (Drug) $32.18
- Rayaldee (Drug) $29.80
- LOKELMA (Drug) $23.38
- GATTEX (Drug) $21.93
- Uloric (Drug) $18.72
- VENOVO (Device) $18.05
- Parsabiv (Biological) $12.05
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.